VitaSpring Biomedical Co. Ltd. (OTCPK: VSBC)
Health Care · Biotechnology · US
$—
— today · — 1Y
VitaSpring Biomedical Co. Ltd. (OTCPK: VSBC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.30M and employs 1 people.
trading between 0.01 and 1.00.
Tweenvest scores VitaSpring Biomedical Co. Ltd. across four factors: quality 35/100, value 69/100. Its strongest factor is value.
VSBC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.30M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -1.96
- 52-week high
- $1.00
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 207.03M
- Employees
- 1
- Next earnings
- —
About VitaSpring Biomedical Co. Ltd.
VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine. It previously operated as Shemn Corp. before rebranding as VitaSpring Biomedical Co. Ltd. in February 2020. The company was established in 2016 and its main operations are based in Irvine, California.
- ISIN
- US92851B1026
- Founded
- 2016
- Listed since
- Nov 13, 2019
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| International Stem Cell CorporationOTCPK: ISCO | $2.32M | $0.29 | -16.08% |
| Oncology Pharma Inc.OTCPK: ONPH | $2.32M | $0.06 | +50.00% |
| Silo Pharma, Inc.NasdaqCM: SILO | $2.32M | $1.45 | -0.55% |
| Valion Bio, Inc.NasdaqCM: VBIO | $2.30M | $2.21 | -14.67% |
| Ocean Sciences LtdASX: BP8 | $2.29M | AU$0.01 | +7.69% |
| Lakewood-Amedex Biotherapeutics, Inc.NasdaqCM: LABT | $2.21M | $0.79 | -15.08% |
| Oragenics, Inc.NYSEAM: OGEN | $2.20M | $0.46 | -5.04% |
| BioAtla, Inc.OTCPK: BCAB | $2.18M | $1.31 | -11.49% |
Figures last refreshed Oct 4, 2026.